Collectively, miRNA involvement in positive/negative feedback loops that regulate ERα activity can, at times, produce contradictory cellular responses, which further underscores the complexity of these regulatory networks that need to be unraveled to advance the potential development of miRNA-targeting therapeutics for ER+ breast cancer. This evidence concerns the gene ESR1 and breast cancer.